Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors
- 1 October 2016
- journal article
- Published by Elsevier in Bioorganic Chemistry
- Vol. 68, 177-186
Abstract
No abstract availableKeywords
Funding Information
- Higher Education Commission of Pakistan
This publication has 43 references indexed in Scilit:
- Synthesis and biological evaluation of novel coumarin–pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agentsEuropean Journal of Medicinal Chemistry, 2013
- ProSep Inc, CanadaFiltration Industry Analyst, 2012
- Aldose reductase inhibitory activity and antioxidant capacity of pomegranate extractsInterdisciplinary Toxicology, 2012
- IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030Diabetes Research and Clinical Practice, 2011
- Coumarin−Purine Ribofuranoside Conjugates as New Agents against Hepatitis C VirusJournal of Medicinal Chemistry, 2011
- Structure of aldehyde reductase in ternary complex with a 5-arylidene-2,4-thiazolidinedione aldose reductase inhibitorEuropean Journal of Medicinal Chemistry, 2010
- A New Series of 1,3‐Dihidro‐Imidazo[1,5‐c]thiazole‐5,7‐Dione Derivatives: Synthesis and Interaction with Aβ(25‐35) Amyloid PeptideChemical Biology & Drug Design, 2009
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Studying plant-derived coumarins for their pharmacological and therapeutic properties as potential anticancer drugsExpert Opinion on Drug Discovery, 2007
- Synthesis of some new 5-(2-substituted-1,3-thiazol-5-yl)-2-hydroxy benzamides and their 2-alkoxy derivatives as possible antifungal agentsEuropean Journal of Medicinal Chemistry, 2004